← Leaderboards
Tamara L Doering
Washington University
$20,134,929
Attributed
$22,803,486
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,803,486 · 19
By mechanism
R01$18,591,817 · 9
R21$4,211,669 · 10
Top collaborators
- Michael R Brent12 shared
- Tuo Wang1 shared
Most similar at Washington University
Same institution · by research overlap
- Maziar Divangahi$989,249
- James Stacey Klutts$91,272
- Lucy Li$326,138
Others in their field
Top investigators on “Cryptococcus Neoformans”
- Arturo Casadevall · Johns Hopkins University$33,951,910
- Joseph Heitman · Duke University$33,924,189
- Hiten D Madhani · University Of California, San Francisco$24,815,163
- Maurizio Del Poeta · Northport Va Medical Center$22,300,489
- Stuart M Levitz · Duke University$16,533,146
- Jennifer K. Lodge · Duke University$14,144,715
Research focus
Cryptococcus NeoformansVirulenceBiologyOrganismFungusPathogenesisPathogenCryptococcusInvestigationAreaInfectionMutantInsightProteinsCellsPolysaccharidesFascinateImmunocompromised HostMeningoencephalitisMicrobeSeverity Of IllnessGrowthMolecularGenes
Grant awards (66)
Solving the puzzle of beta-1,6-glucan in the cryptococcal cell wall$773,053
R01 · FY2025 · AI · contact PI
Natural genomic variants that influence cryptococcal pathogenicity$583,385
R01 · FY2024 · AI · contact PI
Leveraging genomic approaches to define sterol transport in Cryptococcus neoformans$233,250
R21 · FY2024 · AI · contact PI
Filling gaps in the cryptococcal wall with glycogen and a novel enzyme$194,375
R21 · FY2024 · AI · contact PI
Natural genomic variants that influence cryptococcal pathogenicity$593,714
R01 · FY2023 · AI · contact PI
Filling gaps in the cryptococcal wall with glycogen and a novel enzyme$234,001
R21 · FY2023 · AI · contact PI
Leveraging genomic approaches to define sterol transport in Cryptococcus neoformans$194,792
R21 · FY2023 · AI · contact PI
Natural genomic variants that influence cryptococcal pathogenicity$590,438
R01 · FY2022 · AI · contact PI
CRYPTOCOCCAL GLYCAN SYNTHESIS$470,602
R01 · FY2022 · AI · contact PI
Natural genomic variants that influence cryptococcal pathogenicity$612,207
R01 · FY2021 · AI · contact PI
CRYPTOCOCCAL GLYCAN SYNTHESIS$490,920
R01 · FY2021 · AI · contact PI
Natural genomic variants that influence cryptococcal pathogenicity$614,184
R01 · FY2020 · AI · contact PI
CRYPTOCOCCAL GLYCAN SYNTHESIS$514,120
R01 · FY2020 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$450,282
R01 · FY2020 · AI · contact PI
CRYPTOCOCCAL GLYCAN SYNTHESIS$554,268
R01 · FY2019 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$451,415
R01 · FY2019 · AI · contact PI
MITOCHONDRIAL REGULATION IN CRYPTOCOCCUS NEOFORMANS$196,093
R21 · FY2019 · AI · contact PI
Cryptococcal factors in host cell interactions$195,937
R21 · FY2019 · AI · contact PI
CRYPTOCOCCAL GLYCAN SYNTHESIS$475,506
R01 · FY2018 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$453,703
R01 · FY2018 · AI · contact PI
MITOCHONDRIAL REGULATION IN CRYPTOCOCCUS NEOFORMANS$232,876
R21 · FY2018 · AI · contact PI
Cryptococcal factors in host cell interactions$232,500
R21 · FY2018 · AI · contact PI
IDENTIFICATION OF NATURAL GENOMIC VARIANTS THAT INFLUENCE CRYPTOCOCCAL VIRULENCE$190,625
R21 · FY2018 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$454,761
R01 · FY2017 · AI · contact PI
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS$408,654
R01 · FY2017 · AI · contact PI
IDENTIFICATION OF NATURAL GENOMIC VARIANTS THAT INFLUENCE CRYPTOCOCCAL VIRULENCE$228,750
R21 · FY2017 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$457,325
R01 · FY2016 · AI · contact PI
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS$430,086
R01 · FY2016 · AI · contact PI
ENDOTHELIAL FACTORS IN CRYPTOCOCCAL MIGRATION ACROSS THE BLOOD-BRAIN BARRIER$190,625
R21 · FY2016 · AI · contact PI
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS$442,806
R01 · FY2015 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$380,000
R01 · FY2015 · AI · contact PI
ENDOTHELIAL FACTORS IN CRYPTOCOCCAL MIGRATION ACROSS THE BLOOD-BRAIN BARRIER$228,750
R21 · FY2015 · AI · contact PI
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANS$190,625
R21 · FY2015 · AI · contact PI
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS$481,167
R01 · FY2014 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$380,000
R01 · FY2014 · AI · contact PI
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANS$228,500
R21 · FY2014 · AI · contact PI
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS$425,982
R01 · FY2013 · AI · contact PI
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS$393,162
R01 · FY2013 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$357,200
R01 · FY2013 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$380,000
R01 · FY2012 · AI · contact PI
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS$372,438
R01 · FY2012 · AI · contact PI
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS$49,070
R01 · FY2012 · AI · contact PI
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS$380,000
R01 · FY2011 · AI · contact PI
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS$372,438
R01 · FY2011 · AI · contact PI
A NOVEL GLYCAN SYNTHETIC ACTIVITY IN CRYPTOCOCCUS NEOFORMANS$188,100
R21 · FY2011 · AI · contact PI
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS$376,200
R01 · FY2010 · AI · contact PI
GLYCAN BIOSYNTHESIS IN CRYPTOCOCCUS NEOFORMANS$301,807
R01 · FY2010 · GM · contact PI
A NOVEL GLYCAN SYNTHETIC ACTIVITY IN CRYPTOCOCCUS NEOFORMANS$228,000
R21 · FY2010 · AI · contact PI
HOST FACTORS IN CRYPTOCOCCAL INFECTION$225,720
R21 · FY2010 · AI · contact PI
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS$380,000
R01 · FY2009 · AI · contact PI
GLYCAN BIOSYNTHESIS IN CRYPTOCOCCUS NEOFORMANS$311,600
R01 · FY2009 · GM · contact PI
HOST FACTORS IN CRYPTOCOCCAL INFECTION$190,000
R21 · FY2009 · AI · contact PI
Polysaccharide capsule export in the fungal pathogen Cryptococcus neoformans$186,390
R21 · FY2008 · AI · contact PI
Glycan Biosynthesis in Cryptococcus neoformans$308,277
R01 · FY2007 · GM · contact PI
Polysaccharide capsule export in the fungal pathogen Cryptococcus neoformans$221,760
R21 · FY2007 · AI · contact PI
Glycan Biosynthesis in Cryptococcus neoformans$317,484
R01 · FY2006 · GM · contact PI
Glycan Biosynthesis in Cryptococcus neoformans$325,125
R01 · FY2005 · GM
Synthesis &transport of cryptococcal capsule precursors$254,363
R01 · FY2005 · GM
Glycan Biosynthesis in Cryptococcus neoformans$325,125
R01 · FY2004 · GM
Synthesis &transport of cryptococcal capsule precursors$267,750
R01 · FY2004 · GM
Glycan Biosynthesis in Cryptococcus neoformans$281,837
R01 · FY2003 · AI
Synthesis &transport of cryptococcal capsule precursors$267,750
R01 · FY2003 · GM
Synthesis &transport of cryptococcal capsule precursors$281,138
R01 · FY2002 · GM
Glycan Biosynthesis in Cryptococcus neoformans$273,629
R01 · FY2002 · AI
Glycan Biosynthesis in Cryptococcus neoformans$265,731
R01 · FY2001 · AI
Glycan Biosynthesis in Cryptococcus neoformans$261,115
R01 · FY2000 · AI